Journal of Critical Care
Volume 24, Issue 3 , Pages 364-370 , September 2009

Prognosis and 1-year mortality of intensive care unit patients with severe hepatic encephalopathy

References 

  1. Wong F, Bernardi M, Balk R, et al. Sepsis in cirrhosis: report on the 7th meeting of the International Ascites Club. Gut. 2005;54:718–725
  2. Peter Ferenci AL, Mullen K, Tarter R, Weissenborn K, Blei AT. Hepatic encephalopathy—definition, nomenclature, diagnosis, and quantification: final report of the Working Party at the 11th World Congresses of Gastroenterology, Vienna, 1998. Hepatology. 2002;35:716–721
  3. Blei AT, Cordoba J. Hepatic encephalopathy. Am J Gastroenterol. 2001;96:1968–1976
  4. Wright G, Jalan R. Management of hepatic encephalopathy in patients with cirrhosis. Best Pract Res Clin Gastroenterol. 2007;21:95–110
  5. Shellman RG, Fulkerson WJ, DeLong E, et al. Prognosis of patients with cirrhosis and chronic liver disease admitted to the medical intensive care unit. Crit Care Med. 1988;16:671–678
  6. Kress JP, Rubin A, Pohlman AS, et al. Outcomes of critically ill patients denied consideration for liver transplantation. Am J Respir Crit Care Med. 2000;162:418–423
  7. Singh N, Gayowski T, Wagener MM, et al. Outcome of patients with cirrhosis requiring intensive care unit support: prospective assessment of predictors of mortality. J Gastroenterol. 1998;33:73–79
  8. Bone RC, Balk RA, Cerra FB, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest. 1992;101:1644–1655
  9. Ginès P, Guevara M, Arroyo V, et al. Hepatorenal syndrome. Lancet. 2003;362:1819–1827
  10. Le Gall JR, Klar J, Lemeshow S, et al. The Logistic Organ Dysfunction system. A new way to assess organ dysfunction in the intensive care unit. ICU Scoring Group. JAMA. 1996;276:802–810
  11. Le Gall JR, Lemeshow S, Saulnier F. A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA. 1993;270:2957–2963
  12. Butterworth RF. Hepatic encephalopathy: a neuropsychiatric disorder involving multiple neurotransmitter systems. Curr Opin Neurol. 2000;13:721–727
  13. Als-Nielsen B, Gluud LL, Gluud C. Non-absorbable disaccharides for hepatic encephalopathy: systematic review of randomised trials. BMJ. 2004;328:1046
  14. Barbaro G, Di Lorenzo G, Soldini M, et al. Flumazenil for hepatic encephalopathy grade III and IVa in patients with cirrhosis: an Italian multicenter double-blind, placebo-controlled, cross-over study. Hepatology. 1998;28:374–378
  15. Aggarwal A, Ong JP, Younossi ZM, et al. Predictors of mortality and resource utilization in cirrhotic patients admitted to the medical ICU. Chest. 2001;119:1489–1497
  16. Arabi Y, Ahmed QA, Haddad S, et al. Outcome predictors of cirrhosis patients admitted to the intensive care unit. Eur J Gastroenterol Hepatol. 2004;16:333–339
  17. Rabe C, Schmitz V, Paashaus M, et al. Does intubation really equal death in cirrhotic patients? Factors influencing outcome in patients with liver cirrhosis requiring mechanical ventilation. Intensive Care Med. 2004;30:1564–1571
  18. Gildea TR, Cook WC, Nelson DR, et al. Predictors of long-term mortality in patients with cirrhosis of the liver admitted to a medical ICU. Chest. 2004;126:598–603
  19. Benhaddouch Z, Abidi K, Naoufel M, et al. Mortality and prognostic factors of the cirrhotic patients with hepatic encephalopathy admitted to medical intensive care unit. Ann Fr Anesth Reanim. 2007;26:490–495
  20. Goldfarb G, Nouel O, Poynard T, et al. Efficiency of respiratory assistance in cirrhotic patients with liver failure. Intensive Care Med. 1983;9:271–273
  21. Fernández J, Escorsell A, Zabalza M, et al. Adrenal insufficiency in patients with cirrhosis and septic shock: effect of treatment with hydrocortisone on survival. Hepatology. 2006;44:1288–1295
  22. Du Cheyron D, Bouchet B, Parienti JJ, et al. The attributable mortality of acute renal failure in critically ill patients with liver cirrhosis. Intensive Care Med. 2005;31:1693–1699
  23. Chen YC, Tsai MH, Hsu CW, et al. Role of serum creatinine and prognostic scoring systems in assessing hospital mortality in critically ill cirrhotic patients with upper gastrointestinal bleeding. J Nephrol. 2003;16:558–565
  24. Ho YP, Chen YC, Yang C, et al. Outcome prediction for critically ill cirrhotic patients: a comparison of APACHE II and Child-Pugh scoring systems. J Intensive Care Med. 2004;19:105–110
  25. Wehler M, Kokoska J, Reulbach U, et al. Short-term prognosis in critically ill patients with cirrhosis assessed by prognostic scoring systems. Hepatology. 2001;34:255–261
  26. Cholongitas E, Senzolo M, Patch D, et al. Risk factors, sequential organ failure assessment and model for end-stage liver disease scores for predicting short term mortality in cirrhotic patients admitted to intensive care unit. Aliment Pharmacol Ther. 2006;23:883–893
  27. Chen YC, Tsai MH, Ho YP, et al. Comparison of the severity of illness scoring systems for critically ill cirrhotic patients with renal failure. Clin Nephrol. 2004;61:111–118
  28. Ong JP, Aggarwal A, Krieger D, et al. Correlation between ammonia levels and the severity of hepatic encephalopathy. Am J Med. 2003;114:188–193

☆ No funding support was received for this work. None of the authors are involved in any commercial or noncommercial affiliations or consultancies that are, or may be perceived to be, in conflict of interest with the work.

PII: S0883-9441(09)00011-2

doi: 10.1016/j.jcrc.2009.01.008

Journal of Critical Care
Volume 24, Issue 3 , Pages 364-370 , September 2009

Article Tools

* Image Usage & Resolution